{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:13:30Z","timestamp":1790856810885,"version":"4.1.0"},"reference-count":88,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Low-density lipoprotein receptor-related protein 5 (LRP5) is a multifunctional transmembrane coreceptor that plays a pivotal role in development and disease. Wnt\/\u03b2-catenin signaling is the primary downstream signaling pathway activated by LRP5. Furthermore, some LRP5 functions are mediated by noncanonical pathways, such as AKT\/P21 and TGF-\u03b2\/Smad signaling. Pathologically, both loss-of-function and gain-of-function mutations in LRP5 produce distinct phenotypes, ranging from osteoporosis-pseudoglioma syndrome to high bone mass disorders. Beyond the skeletal system, LRP5 has emerged as a key regulator of retinal angiogenesis, vascular integrity, renal tubular function, neurodevelopment, and lipid metabolism. Its physiological functions are highlighted by its ability to influence adipocyte differentiation, insulin sensitivity, and neuronal synaptic plasticity. Moreover, LRP5 displays a dual role in development and disease progression. Although it plays a protective role in acute injuries such as myocardial infarction and acute kidney injury, LRP5 also contributes to chronic pathologies such as tubulointerstitial fibrosis, polycystic kidney disease, and atherosclerosis through fibrotic and inflammatory pathways. Recent therapeutic interest has focused on modulating LRP5 activity using agents such as anti-Dickkopf-related protein 1 antibody, sclerostin inhibitors, polyclonal antibodies, CRISPR\/Cas9 knockout, and some natural products. This review discusses the current understanding of LRP5's physiological and pathological roles across organ systems and highlights its therapeutic potential, emphasizing the need for targeted approaches considering its context-dependent effects.<\/jats:p>","DOI":"10.3390\/cells14171391","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T14:53:01Z","timestamp":1757083981000},"page":"1391","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["LRP5: A Multifaceted Co-Receptor in Development, Disease, and Therapeutic Target"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0804-2339","authenticated-orcid":false,"given":"Abdulmajeed F.","family":"Alrefaei","sequence":"first","affiliation":[{"name":"Department of Biology\/Genetic and Molecular Biology Central Laboratory (GMCL), Jamoum University College, Umm Al-Qura University, Makkah 2203, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41580-024-00823-y","article-title":"Mechanistic insights into Wnt-\u03b2-catenin pathway activation and signal transduction","volume":"26","author":"Maurice","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-Catenin Signaling, Disease, and Emerging Therapeutic Modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Alrefaei, A.F., M\u00fcnsterberg, A.E., and Wheeler, G.N. (2020). FZD10 regulates cell proliferation and mediates Wnt1 induced neurogenesis in the developing spinal cord. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0219721"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101613","DOI":"10.1016\/j.jksus.2021.101613","article-title":"Frizzled receptors (FZD) play multiple cellular roles in development, in diseases, and as potential therapeutic targets","volume":"33","author":"Alrefaei","year":"2021","journal-title":"J. King Saud Univ. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/CIRCRESAHA.110.219840","article-title":"An updated overview on Wnt signaling pathways: A prelude for more","volume":"106","author":"Rao","year":"2010","journal-title":"Circ. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"MacDonald, B.T., and He, X. (2012). Frizzled and LRP5\/6 receptors for Wnt\/\u03b2-catenin signaling. Cold Spring Harb. Perspect. Biol., 4.","DOI":"10.1101\/cshperspect.a007880"},{"key":"ref_7","first-page":"1663","article-title":"LDL receptor-related proteins 5 and 6 in Wnt\/beta-catenin signaling: Arrows point the way","volume":"131","author":"He","year":"2004","journal-title":"Dev. Camb. Engl."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Alrefaei, A.F., and Abu-Elmagd, M. (2022). LRP6 Receptor Plays Essential Functions in Development and Human Diseases. Genes, 13.","DOI":"10.3390\/genes13010120"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ren, Q., Chen, J., and Liu, Y. (2021). LRP5 and LRP6 in Wnt Signaling: Similarity and Divergence. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.670960"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tem.2012.10.003","article-title":"LRP5 and LRP6 in development and disease","volume":"24","author":"Joiner","year":"2013","journal-title":"Trends Endocrinol. Metab. TEM"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ajpath.2021.11.007","article-title":"LRP5 Promotes Gastric Cancer via Activating Canonical Wnt\/\u03b2-Catenin and Glycolysis Pathways","volume":"192","author":"Nie","year":"2022","journal-title":"Am. J. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/jor.20356","article-title":"Blocking Wnt\/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells","volume":"25","author":"Guo","year":"2007","journal-title":"J. Orthop. Res. Off. Publ. Orthop. Res. Soc."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Riddle, R.C., Diegel, C.R., Leslie, J.M., Van Koevering, K.K., Faugere, M.-C., Clemens, T.L., and Williams, B.O. (2013). Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisition. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063323"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1172\/JCI76431","article-title":"Canonical WNT signaling components in vascular development and barrier formation","volume":"124","author":"Zhou","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e59489","DOI":"10.7554\/eLife.59489","article-title":"Wnt3 distribution in the zebrafish brain is determined by expression, diffusion and multiple molecular interactions","volume":"9","author":"Veerapathiran","year":"2020","journal-title":"eLife"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1073\/pnas.0133792100","article-title":"Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion","volume":"100","author":"Fujino","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1210\/jc.2016-1594","article-title":"Wnt Signaling Genes in Adipose Tissue and Skeletal Muscle of Humans With Different Degrees of Insulin Sensitivity","volume":"101","author":"Stefanowicz","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00247-024-05998-2","article-title":"Osteoporosis-pseudoglioma syndrome","volume":"54","author":"Kandula","year":"2024","journal-title":"Pediatr. Radiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/iovs.62.15.4","article-title":"Ocular Features and Mutation Spectrum of Patients With Familial Exudative Vitreoretinopathy","volume":"62","author":"Tao","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","article-title":"High bone density due to a mutation in LDL-receptor-related protein 5","volume":"346","author":"Boyden","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/eurheartj\/ehr062","article-title":"Wnt pathway activation, cell migration, and lipid uptake is regulated by low-density lipoprotein receptor-related protein 5 in human macrophages","volume":"32","author":"Romero","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41392-020-0142-x","article-title":"A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-\u03b2\/Smad signaling","volume":"5","author":"He","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.7150\/jca.93585","article-title":"Knockdown of LRP5 Promotes Proliferation and Invasion of Tongue Squamous Cell Carcinoma through Compensatory Activation of Akt Signaling","volume":"15","author":"Wang","year":"2024","journal-title":"J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1111\/jcmm.17311","article-title":"LRP5 regulates cardiomyocyte proliferation and neonatal heart regeneration by the AKT\/P21 pathway","volume":"26","author":"Zhou","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/pr.2013.42","article-title":"Inhibition of LRP5\/6-mediated Wnt\/\u03b2-catenin signaling by Mesd attenuates hyperoxia-induced pulmonary hypertension in neonatal rats","volume":"73","author":"Alapati","year":"2013","journal-title":"Pediatr. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00198-024-07080-x","article-title":"Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass","volume":"35","author":"Ren","year":"2024","journal-title":"Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"23698","DOI":"10.1074\/jbc.M601000200","article-title":"The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment","volume":"281","author":"Sawakami","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Maeda, K., Kobayashi, Y., Koide, M., Uehara, S., Okamoto, M., Ishihara, A., Kayama, T., Saito, M., and Marumo, K. (2019). The Regulation of Bone Metabolism and Disorders by Wnt Signaling. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20225525"},{"key":"ref_29","first-page":"1","article-title":"Sclerostin, an emerging therapeutic target for treating osteoporosis and osteoporotic fracture: A general review","volume":"4","author":"Suen","year":"2016","journal-title":"J. Orthop. Transl."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Mehta, P., Sharma, A., Goswami, A., Gupta, S.K., Singhal, V., Srivastava, K.R., Chattopadhyay, N., and Singh, R. (2024). Case report: Exome sequencing identified mutations in the LRP5 and LGR4 genes in a case of osteoporosis with recurrent fractures and extraskeletal manifestations. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1475446"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/CIRCULATIONAHA.111.040337","article-title":"Wnt signaling mediates pathological vascular growth in proliferative retinopathy","volume":"124","author":"Chen","year":"2011","journal-title":"Circulation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"108977","DOI":"10.1016\/j.exer.2022.108977","article-title":"Structure and function of the retina of low-density lipoprotein receptor-related protein 5 (Lrp5)-deficient rats","volume":"217","author":"Ubels","year":"2022","journal-title":"Exp. Eye Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/crispr.2020.0009","article-title":"Low-Density Lipoprotein Receptor-Related Protein 5-Deficient Rats Have Reduced Bone Mass and Abnormal Development of the Retinal Vasculature","volume":"3","author":"Ubels","year":"2020","journal-title":"CRISPR J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4103\/jpn.JPN_107_20","article-title":"Osteoporosis Pseudoglioma Syndrome","volume":"15","author":"Gowda","year":"2020","journal-title":"J. Pediatr. Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e42702","DOI":"10.1097\/MD.0000000000042702","article-title":"An analysis of LRP5 gene frequencies in infants with familial exudative vitreoretinopathy in Chongqing and Urumqi","volume":"104","author":"Cen","year":"2025","journal-title":"Medicine"},{"key":"ref_36","unstructured":"Luvisi, J.R., and Blair, K. (2025, September 02). Familial Exudative Vitreoretinopathy (FEVR), StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK614159\/."},{"key":"ref_37","first-page":"476","article-title":"Genetic variants of FZD4 and LRP5 genes in patients with advanced retinopathy of prematurity","volume":"19","author":"Kondo","year":"2013","journal-title":"Mol. Vis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"NP8","DOI":"10.1177\/11206721241254129","article-title":"Unveiling novel LRP5 pathogenic variant in familial exudative vitreoretinopathy: Diverse phenotypic expressions in a mother-daughter duo","volume":"34","author":"Chang","year":"2024","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/eurheartj\/eht309.3413","article-title":"LRP5 modulates the Wnt signalling pathway to protect cardiac cells","volume":"34","author":"Borrell","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.atherosclerosis.2014.05.922","article-title":"Cholesterol modulates LRP5 expression in the vessel wall","volume":"235","author":"Romero","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijcard.2018.06.029","article-title":"LRP5 controls cardiac QT interval by modulating the metabolic homeostasis of L-type calcium channel","volume":"275","author":"Liang","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1165\/rcmb.2015-0045OC","article-title":"Acceleration of Lung Regeneration by Platelet-Rich Plasma Extract through the Low-Density Lipoprotein Receptor-Related Protein 5-Tie2 Pathway","volume":"54","author":"Mammoto","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/path.4121","article-title":"Wnt signalling in kidney diseases: Dual roles in renal injury and repair","volume":"229","author":"Kawakami","year":"2013","journal-title":"J. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/s41418-022-01026-8","article-title":"B7-1 mediates podocyte injury and glomerulosclerosis through communication with Hsp90ab1-LRP5-\u03b2-catenin pathway","volume":"29","author":"Li","year":"2022","journal-title":"Cell Death Differ."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/ejhg.2015.86","article-title":"LRP5 variants may contribute to ADPKD","volume":"24","author":"Cnossen","year":"2016","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"115114","DOI":"10.1016\/j.intimp.2025.115114","article-title":"The BPIFA2-LRP5 axis orchestrates mitochondrial dysfunction to mediate kidney injury in lupus nephritis","volume":"162","author":"Liu","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3-OR","DOI":"10.2337\/db25-3-OR","article-title":"3-OR: LRP5 Promotes Fatty Acid Oxidation to Reduce Lipid Deposition in the Proximal Tubules of DKD Kidneys","volume":"74","author":"HE","year":"2025","journal-title":"Diabetes"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ajmg.b.32695","article-title":"The involvement of the canonical Wnt-signaling receptor LRP5 and LRP6 gene variants with ADHD and sexual dimorphism: Association study and meta-analysis","volume":"180","author":"Nemoda","year":"2019","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cvr\/cvad159","article-title":"Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function","volume":"120","author":"Luquero","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Luquero, A., Pimentel, N., Vilahur, G., Badimon, L., and Borrell-Pages, M. (2024). Unique Splicing of Lrp5 in the Brain: A New Player in Neurodevelopment and Brain Maturation. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25126763"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Queiroz, M.P., da Lima, M.S., Barbosa, M.Q., de Melo, M.F.F.T., de Bertozzo, C.C.M.S., de Oliveira, M.E.G., Bessa, R.J.B., Alves, S.P.A., Souza, M.I.A., and de do Queiroga, R.C.R.E. (2019). Effect of Conjugated Linoleic Acid on Memory and Reflex Maturation in Rats Treated During Early Life. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.00370"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Willems, B., Tao, S., Yu, T., Huysseune, A., Witten, P.E., and Winkler, C. (2015). The Wnt Co-Receptor Lrp5 Is Required for Cranial Neural Crest Cell Migration in Zebrafish. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131768"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13041-015-0183-1","article-title":"Lrp5\/6 are required for cerebellar development and for suppressing TH expression in Purkinje cells via \u03b2-catenin","volume":"9","author":"Huang","year":"2016","journal-title":"Mol. Brain"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Geng, S., Paul, F., Kowalczyk, I., Raimundo, S., Sporbert, A., Mamo, T.M., and Hammes, A. (2023). Balancing WNT signalling in early forebrain development: The role of LRP4 as a modulator of LRP6 function. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1173688"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s43856-025-00774-1","article-title":"LRP5 promotes adipose progenitor cell fitness and adipocyte insulin sensitivity","volume":"5","author":"Loh","year":"2025","journal-title":"Commun. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cmet.2015.01.009","article-title":"LRP5 regulates human body fat distribution by modulating adipose progenitor biology in a dose- and depot-specific fashion","volume":"21","author":"Loh","year":"2015","journal-title":"Cell Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"11795514241307180","DOI":"10.1177\/11795514241307180","article-title":"The Relationship Between LRP-5 and LRP-6 Gene Mutations and Postmenopausal Type 2 Diabetes and Obesity","volume":"18","author":"Li","year":"2025","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41698-024-00555-4","article-title":"Recurrent UBE3C-LRP5 translocations in head and neck cancer with therapeutic implications","volume":"8","author":"Dharavath","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Bj\u00f6rklund, P., Svedlund, J., Olsson, A.-K., Akerstr\u00f6m, G., and Westin, G. (2009). The internally truncated LRP5 receptor presents a therapeutic target in breast cancer. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004243"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"22586","DOI":"10.18632\/oncotarget.25187","article-title":"LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers","volume":"9","author":"Maubant","year":"2018","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1172\/JCI93198","article-title":"JAM3 maintains leukemia-initiating cell self-renewal through LRP5\/AKT\/\u03b2-catenin\/CCND1 signaling","volume":"128","author":"Zhang","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Bj\u00f6rklund, P., Akerstr\u00f6m, G., and Westin, G. (2007). An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT\/beta-catenin signaling. PLoS Med., 4.","DOI":"10.1371\/journal.pmed.0040328"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41388-018-0532-5","article-title":"Hsp90ab1 stabilizes LRP5 to promote epithelial-mesenchymal transition via activating of AKT and Wnt\/\u03b2-catenin signaling pathways in gastric cancer progression","volume":"38","author":"Wang","year":"2019","journal-title":"Oncogene"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/cam4.111","article-title":"LRP5 knockdown: Effect on prostate cancer invasion growth and skeletal metastasis in vitro and in vivo","volume":"2","author":"Rabbani","year":"2013","journal-title":"Cancer Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tranon.2016.08.010","article-title":"LRP5 Signaling in Osteosarcomagenesis: A Cautionary Tale of Translation from Cell Lines to Tumors","volume":"9","author":"Horne","year":"2016","journal-title":"Transl. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"990","DOI":"10.7150\/ijms.99920","article-title":"LRP5 enhances glioma cell proliferation by modulating the MAPK\/p53\/cdc2 pathway","volume":"22","author":"Feng","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"ref_67","first-page":"218","article-title":"A novel polypeptide encoded by circSPIRE1 promotes prostate cancer proliferation and migration by restraining the ubiquitin-dependent degradation of LRP5","volume":"44","author":"Hu","year":"2025","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/s41388-025-03298-z","article-title":"SNX5 facilitates the progression of gastric cancer by increasing the membrane localization of LRP5","volume":"44","author":"Le","year":"2025","journal-title":"Oncogene"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Correa-Arzate, L., Portilla-Robertson, J., Ram\u00edrez-Jarqu\u00edn, J.O., Jacinto-Alem\u00e1n, L.F., Mej\u00eda-Vel\u00e1zquez, C.P., Villanueva-S\u00e1nchez, F.G., and Rodr\u00edguez-V\u00e1zquez, M. (2023). LRP5, SLC6A3, and SOX10 Expression in Conventional Ameloblastoma. Genes, 14.","DOI":"10.3390\/genes14081524"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Pan, Y., Wang, S., Duan, G., Wu, J., Feng, F., Chen, L., Li, A., Xu, K., Wang, C., and Fan, S. (2025). Natural Product Daidzin Inhibits Glioma Development via Suppressing the LRP5-Mediated GSK-3\u03b2\/c-Myc Signaling Pathway. BioFactors Oxf. Engl., 51.","DOI":"10.1002\/biof.70025"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1182\/blood-2006-09-047712","article-title":"Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo","volume":"109","author":"Yaccoby","year":"2007","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1359\/jbmr.081104","article-title":"Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma","volume":"24","author":"Heath","year":"2009","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/blood-2008-11-191577","article-title":"Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma","volume":"114","author":"Fulciniti","year":"2009","journal-title":"Blood"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.111.181404","article-title":"A rate-limiting role for Dickkopf-1 in bone formation and the remediation of bone loss in mouse and primate models of postmenopausal osteoporosis by an experimental therapeutic antibody","volume":"338","author":"Glantschnig","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1759720X12466608","article-title":"Wnt signaling in bone formation and its therapeutic potential for bone diseases","volume":"5","author":"Kim","year":"2013","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nm.2098","article-title":"Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis","volume":"16","author":"Yadav","year":"2010","journal-title":"Nat. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/jbmr.439","article-title":"Efficacy of serotonin inhibition in mouse models of bone loss","volume":"26","author":"Inose","year":"2011","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2388","article-title":"Lrp5 functions in bone to regulate bone mass","volume":"17","author":"Cui","year":"2011","journal-title":"Nat. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.21037\/apm-22-998","article-title":"Blosozumab in the treatment of postmenopausal women with osteoporosis: A systematic review and meta-analysis","volume":"11","author":"Su","year":"2022","journal-title":"Ann. Palliat. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.15586\/jptcp.v27i1.655","article-title":"Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review","volume":"27","author":"Shakeri","year":"2020","journal-title":"J. Popul. Ther. Clin. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/jbmr.3143","article-title":"BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial","volume":"32","author":"Glorieux","year":"2017","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Tian, Y., Liu, H., Bao, X., and Li, Y. (2025). Semaglutide promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells through activation of the Wnt\/LRP5\/\u03b2-catenin signaling pathway. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1539411"},{"key":"ref_84","unstructured":"PubMed (2025, September 02). LRP5 Down-Regulation Exacerbates Inflammation and Alveolar Bone Loss in Periodontitis by Inhibiting PI3K\/c-FOS Signalling, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/39837316\/."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/tvst.11.9.19","article-title":"SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy","volume":"11","author":"Nguyen","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_86","first-page":"311","article-title":"A Frizzled4\/LRP5 agonist restores retinal pericyte coverage and reduces hemorrhage in a genetic model of pericyte loss","volume":"65","author":"Levey","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-025-01412-7","article-title":"Clinical, Biochemical and Radiological Features of LRP5 Gene Variants in Children","volume":"116","author":"Ubertini","year":"2025","journal-title":"Calcif. Tissue Int."},{"key":"ref_88","unstructured":"PubMed (2025, September 02). Genetic Variants in the LRP5 Gene Associated with Gain and Loss of Bone Mineral Density, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/40255261\/."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/17\/1391\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:41:03Z","timestamp":1760035263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/17\/1391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":88,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cells14171391"],"URL":"https:\/\/doi.org\/10.3390\/cells14171391","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]}}}